Recent advances in brain tumor therapy: application of electrospun nanofibers

Drug Discov Today. 2018 Apr;23(4):912-919. doi: 10.1016/j.drudis.2018.02.007. Epub 2018 Feb 27.

Abstract

Despite much effort to treat glioblastoma multiforme (GBM), the median survival of patients has not significantly improved. The high rate of tumor recurrence after tumor resection and the blood-brain barrier (BBB) decrease the treatment efficacy. Local drug delivery at the surgical resection site via implantable electrospun nanofibers not only circumvents the BBB, but can also reduce the rate of tumor recurrence. Nanofibers can provide a sustained release and a high concentration of chemotherapeutics at the tumor vicinity, while decreasing their systemic exposure and toxicity. In another scenario, aligned nanofibers can mimic the topographical features of the brain extracellular matrix (ECM), which can be utilized for in vitro studies on GBM cell migration. This strategy is beneficial to investigate the interactions of tumor cells with the microenvironment which has a dominant role in regulating tumor formation, progression, and metastasis.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / chemistry*
  • Blood-Brain Barrier / metabolism
  • Brain / drug effects
  • Brain Neoplasms / drug therapy*
  • Drug Delivery Systems / methods
  • Glioblastoma / drug therapy
  • Humans
  • Nanofibers / chemistry*

Substances

  • Antineoplastic Agents